ArticleBMC infectious diseases2026
Epidemiology, clinical outcomes, and factors associated with mortality among cerebrospinal meningitis cases in the Upper West Region of Ghana: an eight-year surveillance study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCerebrospinal meningitis is a clinical syndrome with multiple etiologies, however, in sub-Saharan Africa, infectious and contagious forms remain highly prevalent and carry high risks of mortality and disability. The Upper West Region of Ghana is found within the meningitis belt and frequently records the highest numbers of incident meningitis cases within the country yearly.
methodsThis study analyzed all routinely-collected data on surveillance-defined suspected and confirmed cases of meningitis in the Upper West Region of Ghana between January 2016 and December 2023. The data were obtained from the Disease Surveillance Unit of the region. Descriptive statistics were used to summarize patient characteristics, clinical presentation, consultation delays, and outcomes. Bivariate (unadjusted) analyses were conducted to explore associations between individual covariates and each outcome of interest, and then multivariable logistic regression models and reported adjusted odds ratios were used to find associations.
results407 meningitis-related clinical consultations were recorded. The median age was 13 years (IQR: 4-23 years). More than half of cases (55.3%) occurred among children aged 0-15 years. Males accounted for 55.8% of cases. 32 deaths were recorded during the study period, corresponding to a crude mortality rate of 7.9%. Fever (41.0%), neck stiffness (35.3%), and headache (31.7%) were the most frequently reported symptoms. The median time to first consultation was 2 days (IQR: 1-3 days), and almost half of patients (46.9%) sought care within one day of symptom onset. Those aged ≥ 46 years had significantly higher odds of death (aOR = 6.01, 95% CI: 1.61-22.46). Patients presenting with classic meningitis symptoms had lower odds of death (aOR = 0.38, 95% CI: 0.15-0.97), with patients presenting with other non-specific symptoms having significantly higher odds of death (aOR = 3.84, 95% CI: 1.33-11.05).
conclusionCerebrospinal meningitis affected individuals across all age groups, although the young were disproportionately affected. Older individuals and those with symptoms other than the classic meningitis symptoms had higher odds of mortality. It is important for healthcare workers to recognize this, so that they can maintain a higher index of suspicion especially during outbreaks. Policymakers need to be cognizant of the fact that meningitis remains an important public health concern and that vaccinations; health education and promotion; and targeted interventions for older populations should be prioritized. The public should be educated on the non-specific features of the disease. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.